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Identity 
Other names: MTR; MTHR 




The gene encompasses 19.3 kb of DNA; 11 exons. 
Transcription 
For MTHFR, transcripts of 9.0, 7.2, 6.3, 3.0 and 2.8 kb 
were observed. The different-sized transcripts result 
from alternate transcription start sites and  
multiple polyadenylation signals. The total abundance 




656 amino acids; 74.6 kDa protein. 
Expression 
Expression is more intense in testis, intermediate in 






Probe(s) - Courtesy Mariano Rocchi, Resources for Molecular Cytogenetics. 
 










MTHFR metabolic pathway 
 
Function 
MTHFR catalyzes the conversion of 5, 10- 
methylenetetrahydrofolate to 5-methyltetrahydrofolate, 






Two common polymorphisms 677C-T and 1298A-C 
have been identified. These polymorphisms are 
responsible for the synthesis of a thermolabile form of 
MTHFR. The 677TT genotype was particularly 
common in northern China (20%), southern Italy 
(26%), and Mexico (32%). The 677C>T mutation in 
the MTHFR gene is an important cause of mild 
hyperhomocysteinaemia. The second polymorphism at 
nucleotide position 1298 is not as well characterized. 
Implicated in 




This form of homocystinuria is caused by mutation in 
the 5, 10-alpha-methylenetetrahydrofolate reductase 
gene. This homocystinuria is autosomal recessive and 
shows a wide range of clinical symptoms, such as 
developmental delay, severe mental retardation, 
perinatal death, psychiatric disturbances, and later-
onset neurodegenerative disorders. In the classic form, 
both thermostable and thermolabile enzyme variants 
have been identified. 
Cancer 
Disease 
In some cancers, folate and other nutrients involved in 
the MTHFR metabolic pathway appear to interact with 
MTHFR polymorphisms to further modify cancer risk. 
In most studies, MTHFR 677TT and 1298CC are 
associated with moderately reduced colorectal cancer 
risk, in particular in individuals who had higher folate 
levels. In individuals with low folate intake and/or high 
alcohol consumption, cancer risk may be increased. 
Morever, both adults and children with the variant 
forms of MTHFR seems to have a decreased risk of 
lymphoid leukemias. MTHFR polymorphisms were 
also associated with other cancers as breast, head and 
neck, liver, gastric or lung cancers. 
Oncogenesis 
Reduction of 5, 10-methylenetetrahydrofolate 
(methyleneTHF), a donor for methylating dUMP to 
dTMP in DNA synthesis, to 5-methyltetrahydrofolate 
(methylTHF), the primary methyl donor for methionine 
synthesis, is catalyzed by MTHFR. Diminution in the 
activity of the MTHFR enzyme increases the pool of 
methyleneTHF at the expense of the pool of 
methylTHF. Enhanced availability of methyleneTHF in 
the DNA synthesis pathway reduces misincorporation 
of uracil into DNA, which might otherwise result in 
double-strand breaks during uracil excision repair 
processes, thus increasing the risk of chromosomal 
aberrations. Morever, the MTHFR polymorphisms 
influences DNA methylation status through interaction 
with folate status. 
Coronary Artery Disease 
Disease 
The 677TT MTHFR allele was correlated with 
coronary artery disease. However, the role of this  
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polymorphism in the causation of coronary artery 
disease is controversial. 
Depression 
Disease 
Hyperhomocysteinemia and the 677TT genotype were 
significantly related to depression. 
To be noted 
Note 
MTHFR polymorphisms influence the metabolism of 
folates and could modify the pharmacodynamics of 
antifolates and many other drugs whose metabolism, 
biochemical effects, or target structures require 
methylation reactions. 
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